Dundee is Scottish University of the Year
The University of Dundee has been named Scottish University of the Year in the 2025 edition of the Daily Mail University Guide, published this weekend.
The University of Dundee has been named Scottish University of the Year in the 2025 edition of the Daily Mail University Guide, published this weekend.
New methods to determine which older adults with cancer will tolerate chemotherapy must be developed to improve treatment decisions, a University of Dundee expert has said.
A University of Dundee study has discovered the potential for Artificial Intelligence to transform care for heart failure patients.
The University of Dundee is to spearhead a multi-million-pound clinical trial to find out whether existing drugs could be used to treat people with a debilitating lung disease.
New research shows that people who have faced traumatic or stressful events during childhood, such as abuse or neglect, have a higher risk of experiencing multiple long-term health conditions in ad
Prospect Business Centre comprises three stand-alone units – Prospect House, Prospect 2 and Software Centre – complemented by designated car parking areas for the three individual buildings.
Prospect II comprises a single storey building with glass curtain walling under a pitched profile aluminium roof. The premises are fitted out to provide 5 laboratory suites and benefit from communal kitchen and male and female WC facilities.
Glen Clova Scientific Ltd (GCS) is developing a new generation of Active Biologics to treat inflammatory conditions. We are an ambitious spinout from the University of Dundee (April 2024) aiming to address the global need to make effective treatments available for millions of patients. Our novel Virus-Like-Particle technology is poised to address inherent limitations of the current blockbuster class of Biologic drugs. Our vision is to make high end biotech pharmaceuticals much more accessible to patients than current blockbusters.
GCS will establish and grow its research facilities in the Dundee area. The scientific team continues to grow so if you aspire not only to be at the core of biotech innovation but also to tackle the global problem of high-cost medicine, get in touch.
- Precision-designed potent and selective CDK7 inhibitor with potential for improved therapeutic index -